Business · Companies · 13 hrs ago

MBDI to list on South Korea’s Kosdaq as four firms begin IPO pricing

MBDI to list on South Korea’s Kosdaq as four firms begin IPO pricing

MBDI, a precision-medicine company, is due to list on South Korea’s Kosdaq on Nov.

24.

It uses 3D cell cultures to test how cancer cells respond to drugs and help predict treatment effects.

Its final IPO price was set at 7,000 won per share, below its planned range of 9,600 to 11,700 won.

Four other companies will conduct pricing surveys with institutional investors, which help set their IPO prices.

They are aerospace structures maker ANH Structure, cybersecurity firm Enki WhiteHat, drug developer Innovo Therapeutics and pharmaceutical company Mothers Pharmaceutical.

KMF and ANH Structure will also open share subscriptions to individual investors, on Nov.

24–25 and Nov.

27–30, respectively.

The pricing surveys and subscriptions will continue into early December, with the companies’ final prices and listing plans to follow.

1 source

Related